While part of the team last week was at EuroCD, Tamas Kiss, PhD was also busy.
We had the privilege to present interesting applications of cyclodextrins in the Annual Symposium on Pharmaceutical Chemistry and Pharmaceutical Technology, organized by the Hungarian Chemical Society.
The lecture presented several fascinating cyclodextrin applications, such as:
1. Cyclarity Therapeutics’ solution for reversing arteriosclerosis with a cyclodextrin dimer (they are in Clinical Phase 1)
2. Oculis’ formulation that contains gamma-cyclodextrin-dexamethasone suspension, which could be an alternative to the intravitreal injection (Clinical Phase 3 completed)
3. Fraunhofer Institute for Building Physics IBP’s gel, which binds the toxic vapour (e.g., lindane) that is released from wood preservatives widespread in Germany
